Sandra Umbrecht

Sandra Umbrecht has over 20 years of experience in the pharmaceutical industry. Sandra began their career in 1998 as a Study Coordinator for Toxicology Safety Assessment at Bristol-Myers Squibb. Sandra then moved to Johnson & Johnson as a Research Associate in DMPK and Preclinical DMPK in 2002. Sandra also worked as an Investigator at GSK that same year. In 2013, they joined Teva Pharmaceuticals as a Senior Regulatory Affairs Associate and Publishing Specialist II. In 2016, they were hired as a Regulatory Affairs Manager at Incyte Corporation. In 2019, they became a Senior Manager of Regulatory Affairs at EMD Serono, Inc. and in 2021 they were promoted to Associate Director of Regulatory Affairs at BeiGene. Sandra currently holds the role of Director of Regulatory Affairs at Adlai Nortye USA Inc.

Sandra Umbrecht attended the University of Delaware from 1989 to 1993, where they earned a Bachelor of Science in Agriculture with a field of study in Pre-Veterinary Studies.